Carregant...
mRNA technology as one of the promising platforms for the SARS-CoV-2 vaccine development
After the genome sequence of SARS-CoV-2 (Severe acute respiratory syndrome-related coronavirus 2) was published and the number of infected people began to increase rapidly, many global companies began to develop a vaccine. Almost all known approaches to vaccine design were applied for this purpose,...
Guardat en:
| Autors principals: | , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Institute of Cytology and Genetics of Siberian Branch of the Russian Academy of Sciences
2020-12-01
|
| Col·lecció: | Vavilovskij Žurnal Genetiki i Selekcii |
| Matèries: | |
| Accés en línia: | https://vavilov.elpub.ru/jour/article/view/2824 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|